Pharmaceutical

Cellectar Biosciences to Present Data in Poster Presentation at the American Association for Cancer Research Special Conference on Advances in Pancreatic Cancer Research

FLORHAM PARK, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright’s 27th Annual Global Investment Conference on Monday, September 8th

WILMINGTON, Del., Sept. 03, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage...

Elsevier launches PharmaPendium AI, designed to support faster and more reliable access to regulatory insights for drug development

The solution transforms how insights are gathered from regulatory data, enabling users to quickly identify critical precedents, anticipate approval issues...

Dr. Robert Melillo and ‘A Moment of Xen’ join forces to bring ‘Brain-Based Wellness’ to National Radio, Digital Streaming TV, and social platforms

NEW YORK, Sept. 2, 2025 /PRNewswire/ -- 'A Moment of Xen', the acclaimed Tri-State talk show hosted by celebrated media...

MediSpend and Life Sciences Subsidiary of RLDatix Merge to Form Leading Global Provider of Regulatory and Compliance SaaS Solutions for Life Sciences

New company delivers built-for-purpose, best-in-class solutions spanning the entire product lifecycle for pharmaceutical, biotech, and medical device companies PORTSMOUTH, N.H.,...

Medical Horizons and Bowhead Health Inc. Announce Exclusive Partnership to Bring AI-Powered Clinical Research Solutions to Italy, Turkey, and Cyprus

FLORENCE, Italy, Sept. 2, 2025 /PRNewswire/ -- Medical Horizons S.r.l., (medicalhorizons.it) a leading distributor of Artificial Intelligence (AI) solutions for...

Amorphical Appoints Eden Ben as CEO, as Company Advances Regulatory Pathway for Nano-Amorphous Mineral-Based Therapeutics

Pipeline of Disease-Modifying Therapies Targets Hypoparathyroidism, Pancreatic Cancer, osteoporotic fractures, and Crohn's Disease NES ZIONA, Israel, Sept. 2, 2025 /PRNewswire/ -- Amorphical,...

Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025

New customer launches representing 107,000 lives covered reinforce Dario's B2B2C momentum and recurring revenue growth Dario's multi-condition digital health solutions...

Mass Spectrometry Market Size to Reach USD 10.13 Billion by 2030, Fueled by AI, Multi-Omics, and Next-Gen Healthcare | Mordor Intelligence

HYDERABAD, India, Sept. 2, 2025 /PRNewswire/ -- According to Mordor Intelligence, the global mass spectrometry market, valued at USD 7.16 billion...

error: Content is protected !!